These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39038610)

  • 1. Tetrameric, active PKM2 inhibits IP
    Lemos FO; de Ridder I; Wagner L; Bootman MD; Bultynck G; Yule DI; Parys JB
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119796. PubMed ID: 39038610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-canonical role for pyruvate kinase M2 as a functional modulator of Ca
    Lavik AR; McColl KS; Lemos FO; Kerkhofs M; Zhong F; Harr M; Schlatzer D; Hamada K; Mikoshiba K; Crea F; Bultynck G; Bootman MD; Parys JB; Distelhorst CW
    Biochim Biophys Acta Mol Cell Res; 2022 Apr; 1869(4):119206. PubMed ID: 35026348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Complex Effects of PKM2 and PKM2:IP
    Lemos FO; de Ridder I; Bootman MD; Bultynck G; Parys JB
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.
    Alzayady KJ; Wagner LE; Chandrasekhar R; Monteagudo A; Godiska R; Tall GG; Joseph SK; Yule DI
    J Biol Chem; 2013 Oct; 288(41):29772-84. PubMed ID: 23955339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.
    Schulman JJ; Wright FA; Kaufmann T; Wojcikiewicz RJH
    J Biol Chem; 2013 Aug; 288(35):25340-25349. PubMed ID: 23884412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-xL acts as an inhibitor of IP
    Rosa N; Ivanova H; Wagner LE; Kale J; La Rovere R; Welkenhuyzen K; Louros N; Karamanou S; Shabardina V; Lemmens I; Vandermarliere E; Hamada K; Ando H; Rousseau F; Schymkowitz J; Tavernier J; Mikoshiba K; Economou A; Andrews DW; Parys JB; Yule DI; Bultynck G
    Cell Death Differ; 2022 Apr; 29(4):788-805. PubMed ID: 34750538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological consequences of isoform-specific IP
    Kerkhofs M; Seitaj B; Ivanova H; Monaco G; Bultynck G; Parys JB
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1707-1717. PubMed ID: 29906486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release.
    Alzayady KJ; Wang L; Chandrasekhar R; Wagner LE; Van Petegem F; Yule DI
    Sci Signal; 2016 Apr; 9(422):ra35. PubMed ID: 27048566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 80K-H interacts with inositol 1,4,5-trisphosphate (IP3) receptors and regulates IP3-induced calcium release activity.
    Kawaai K; Hisatsune C; Kuroda Y; Mizutani A; Tashiro T; Mikoshiba K
    J Biol Chem; 2009 Jan; 284(1):372-380. PubMed ID: 18990696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species.
    Bánsághi S; Golenár T; Madesh M; Csordás G; RamachandraRao S; Sharma K; Yule DI; Joseph SK; Hajnóczky G
    J Biol Chem; 2014 Mar; 289(12):8170-81. PubMed ID: 24469450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-associated mutations in inositol 1,4,5-trisphosphate receptor subunits impair channel function.
    Terry LE; Alzayady KJ; Wahl AM; Malik S; Yule DI
    J Biol Chem; 2020 Dec; 295(52):18160-18178. PubMed ID: 33093175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
    Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Ca2+ in triggering inositol 1,4,5-trisphosphate receptor ubiquitination.
    Alzayady KJ; Wojcikiewicz RJ
    Biochem J; 2005 Dec; 392(Pt 3):601-6. PubMed ID: 16134970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of inositol 1,4,5-trisphosphate from IP
    Smith HA; Taylor CW
    J Biol Chem; 2023 Feb; 299(2):102871. PubMed ID: 36621623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein-protein interactions for channel regulation.
    Vervliet T; Parys JB; Bultynck G
    Biochem Soc Trans; 2015 Jun; 43(3):396-404. PubMed ID: 26009182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant IP
    Ando H; Hirose M; Mikoshiba K
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12259-12264. PubMed ID: 30429331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAP tethers IP
    Thillaiappan NB; Smith HA; Atakpa-Adaji P; Taylor CW
    Nat Commun; 2021 Jul; 12(1):4514. PubMed ID: 34301929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor.
    Saleem H; Tovey SC; Molinski TF; Taylor CW
    Br J Pharmacol; 2014 Jul; 171(13):3298-312. PubMed ID: 24628114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75.
    D'Eletto M; Rossin F; Occhigrossi L; Farrace MG; Faccenda D; Desai R; Marchi S; Refolo G; Falasca L; Antonioli M; Ciccosanti F; Fimia GM; Pinton P; Campanella M; Piacentini M
    Cell Rep; 2018 Dec; 25(13):3573-3581.e4. PubMed ID: 30590033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.